Mobile imaging center supports riders on cycling’s biggest stage

| | Health Imaging | Screening

In the Tour de France, every minute matters. For riders who sustain what could be a serious injury, the only way to be evaluated and cleared to continue riding would be to travel off-site to a hospital.

This year, that changed thanks to a mobile medical center equipped with x-ray and ultrsound equipment that radiologists could use to quickly diagnose injuries and get riders back on the road or, if the injury is more serious, heading to receive the appropriate care.

Cycling magazine VeloNews has more on how this technology was implemented at this year’s Tour:

 

Injured riders win time in Tour’s mobile medical center

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.